Alpharma, LLC
Alpharma, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in the development and manufacturing of high-quality generic and specialty pharmaceuticals. With a strong operational presence across North America and Europe, Alpharma focuses on delivering innovative solutions in pain management, anti-infectives, and controlled substances. The company is renowned for its commitment to quality and compliance, ensuring that its products meet rigorous industry standards. Notable achievements include a robust portfolio of FDA-approved medications that cater to diverse therapeutic areas. Alpharma's dedication to research and development, coupled with its strategic partnerships, positions it as a trusted name in the pharmaceutical landscape, continually striving to enhance patient care and accessibility.
DitchCarbon Score
How does Alpharma, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alpharma, LLC's score of 29 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alpharma, LLC's reported carbon emissions
Alpharma, LLC, headquartered in the US, currently does not have available carbon emissions data for the most recent year, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is challenging to assess their climate impact or sustainability efforts. In the absence of concrete data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on reducing their carbon footprints and enhancing sustainability practices. As such, Alpharma may be expected to align with industry standards and pursue climate commitments in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Alpharma, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
